🧬 Could damaged nerves caused by diabetes actually be repaired?

(The information in this article is strictly for general educational and informational purposes and is not a substitute for professional medical advice, diagnosis, or consultation with a doctor.)

Scientists at UTHealth Houston have reported promising results from an experimental antibody treatment designed to block MMP-9, an enzyme linked to diabetic peripheral neuropathy.

In diabetic mice, the targeted antibodies helped regenerate nerve fibers, improve wound healing and reduce degeneration of small nerve fibers. The researchers also reported improved nerve mitochondrial function and increased blood-vessel formation in the skin.

The research included models of both type 1 and type 2 diabetes.

But there is an important limitation: this is still mouse research. The treatment has not yet been established as a therapy for people.

The findings could nevertheless point toward a different strategy for diabetic neuropathy — one aimed at the underlying biological processes contributing to nerve damage rather than simply treating symptoms.

🔬 The next question is whether this approach can eventually be translated safely to human patients.